Back to today’s briefing

Story perspectives

Empress Therapeutics Uses AI to Transform Drug Discovery

1/26/2025

48 10

Summary

Story summary

Empress Therapeutics, established in 2020, harnesses the power of AI to revolutionize drug discovery. Their Chemilogics™ platform delves into genetic data, pinpointing safe and effective small molecules from human-associated microbes. Senior VP Joe Kelleher highlights AI's ability to unveil surprising disease links, paving the way for groundbreaking therapies while safeguarding patient privacy.

1 of 1

Story summary

Empress Therapeutics, established in 2020, harnesses the power of AI to revolutionize drug discovery. Their Chemilogics™ platform delves into genetic data, pinpointing safe and effective small molecules from human-associated microbes. Senior VP Joe Kelleher highlights AI's ability to unveil surprising disease links, paving the way for groundbreaking therapies while safeguarding patient privacy.